Kiadis Pharma has announced the clinical development collaboration for its lead product Atir with Stephan Mielke and Hermann Einsele from the Allogeneic Stem Cell Transplant Center, Division of Hematology and Oncology, Department of Internal Medicine II at the Julius-Maximilians University of Wurzburg, Germany.